AdaptHealth had its Relative Strength (RS) Rating upgraded from 77 to 82 Tuesday.
This unique rating tracks technical performance by showing how a stock's price movement over the last 52 weeks compares to that of other stocks on the major indexes.
Over 100 years of market history reveals that the top-performing stocks typically have an 80 or better RS Rating in the early stages of their moves.
Hone Your Stock-Picking Skills By Focusing On These Factors
AdaptHealth is building a consolidation with an 11.90 buy point. See if the stock can break out in heavy volume.
AdaptHealth showed 0% earnings growth in its most recent report, while sales growth came in at 0%.
The company earns the No. 3 rank among its peers in the Medical-Outpatient/Home Care industry group. Encompass Health is the top-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
